Cargando…
In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The clinical course and the response to therapy are usually assessed with proteinur...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394405/ https://www.ncbi.nlm.nih.gov/pubmed/28473934 http://dx.doi.org/10.1155/2017/1292531 |
_version_ | 1783229726404378624 |
---|---|
author | Trimarchi, H. Paulero, M. Canzonieri, R. Schiel, A. Iotti, A. Costales-Collaguazo, C. Stern, A. Forrester, M. Lombi, F. Pomeranz, V. Iriarte, R. Rengel, T. Gonzalez-Hoyos, I. Muryan, A. Zotta, E. |
author_facet | Trimarchi, H. Paulero, M. Canzonieri, R. Schiel, A. Iotti, A. Costales-Collaguazo, C. Stern, A. Forrester, M. Lombi, F. Pomeranz, V. Iriarte, R. Rengel, T. Gonzalez-Hoyos, I. Muryan, A. Zotta, E. |
author_sort | Trimarchi, H. |
collection | PubMed |
description | IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The clinical course and the response to therapy are usually assessed with proteinuria and serum creatinine. Validated biomarkers have not been identified yet. In this report, we present a case of acute renal injury with proteinuria and microscopic hematuria in a young male. A kidney biopsy disclosed IgA nephropathy. Podocyturia was significantly elevated compared to normal subjects. Proteinuria, renal function, and podocyturia improved promptly after steroids and these variables remained normal after one year of follow-up, when steroids had already been discontinued and patient continued on valsartan and amiloride. Our report demonstrates that podocyturia is critically elevated during an acute episode of IgA nephropathy, and its occurrence may explain the grim long-term prognosis of this entity. Whether podocyturia could be employed in IgA nephropathy as a trustable biomarker for treatment assessment or even for early diagnosis of IgA nephropathy relapses should be further investigated. |
format | Online Article Text |
id | pubmed-5394405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-53944052017-05-04 In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? Trimarchi, H. Paulero, M. Canzonieri, R. Schiel, A. Iotti, A. Costales-Collaguazo, C. Stern, A. Forrester, M. Lombi, F. Pomeranz, V. Iriarte, R. Rengel, T. Gonzalez-Hoyos, I. Muryan, A. Zotta, E. Case Rep Nephrol Case Report IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The clinical course and the response to therapy are usually assessed with proteinuria and serum creatinine. Validated biomarkers have not been identified yet. In this report, we present a case of acute renal injury with proteinuria and microscopic hematuria in a young male. A kidney biopsy disclosed IgA nephropathy. Podocyturia was significantly elevated compared to normal subjects. Proteinuria, renal function, and podocyturia improved promptly after steroids and these variables remained normal after one year of follow-up, when steroids had already been discontinued and patient continued on valsartan and amiloride. Our report demonstrates that podocyturia is critically elevated during an acute episode of IgA nephropathy, and its occurrence may explain the grim long-term prognosis of this entity. Whether podocyturia could be employed in IgA nephropathy as a trustable biomarker for treatment assessment or even for early diagnosis of IgA nephropathy relapses should be further investigated. Hindawi 2017 2017-04-03 /pmc/articles/PMC5394405/ /pubmed/28473934 http://dx.doi.org/10.1155/2017/1292531 Text en Copyright © 2017 H. Trimarchi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Trimarchi, H. Paulero, M. Canzonieri, R. Schiel, A. Iotti, A. Costales-Collaguazo, C. Stern, A. Forrester, M. Lombi, F. Pomeranz, V. Iriarte, R. Rengel, T. Gonzalez-Hoyos, I. Muryan, A. Zotta, E. In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? |
title | In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? |
title_full | In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? |
title_fullStr | In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? |
title_full_unstemmed | In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? |
title_short | In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? |
title_sort | in acute iga nephropathy, proteinuria and creatinine are in the spot, but podocyturia operates in silence: any place for amiloride? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394405/ https://www.ncbi.nlm.nih.gov/pubmed/28473934 http://dx.doi.org/10.1155/2017/1292531 |
work_keys_str_mv | AT trimarchih inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT paulerom inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT canzonierir inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT schiela inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT iottia inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT costalescollaguazoc inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT sterna inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT forresterm inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT lombif inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT pomeranzv inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT iriarter inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT rengelt inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT gonzalezhoyosi inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT muryana inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride AT zottae inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride |